Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Esperance Pharmaceuticals, Inc. Announces Strategic Alliance With MD Anderson Cancer Center

BATON ROUGE, La., Aug. 24, 2015 /PRNewswire/ — Esperance Pharmaceuticals Inc. today announced that it has entered into a strategic alliance agreement with MD Anderson Cancer Center to accelerate the clinical development of its lead anti-cancer candidate EP-100 for the treatment of ovarian cancer and to collaborate on preclinical studies of EP-100 as a treatment for […]

Read More »

Troubled Ariad Leases Almost Half of New HQ to IBM

As the future of Ariad Pharmaceuticals remains in limbo, the company has signed a contract to sublease 41 percent of the new headquarters it built on Binney Street to IBM. Cambridge-based Ariad (Nasdaq: ARIA) disclosed in a regulatory filing today that the computer giant will rent 160,000 square feet of the new building at 75 […]

Read More »

Could Laser Skin Test Replace Biopsy For Melanoma? Lancaster University Study

Skin cancer remains the most common cancer for Americans, and invasive biopsies for lesions that could be dangerous melanomas have long been routine. Now, researchers say they’ve developed a non-invasive test that can spot melanoma skin cancer without a biopsy, according to a new study. Hey, check out all the engineering jobs. Post your resume […]

Read More »

China Worries Could Hurt Pharma’s Health

The big worries on growth hanging over the pharmaceuticals industry are poles apart. Pressure on U.S. drug pricing is casting a shadow over the sector’s most lucrative market. But slowing emerging-market growth, notably in China, shouldn’t be ignored. Emerging-market sales for the big pharmaceuticals firms tracked by Sanford C. Bernstein increased by about 5.5%, year […]

Read More »

Vital Therapies crashes after liver therapy fails trial

Vital Therapies Inc lost three-quarters of its market value after the company said its liver therapy failed to meet its main goal in a late-stage study, raising doubts about the future of the treatment. The company said it would stop two ongoing studies of the cell-based therapy, which is aimed at treating alcohol-induced liver diseases […]

Read More »

Glaxo Sells Drug Rights to Novartis

LONDON— GlaxoSmithKline GSK -3.47 % PLC is selling its remaining rights to a drug for use in treating autoimmune diseases, including multiple sclerosis, to Novartis AG NVS -3.07 % for up to $1 billion, plus royalties. Glaxo said on Friday that Novartis will own rights to ofatumumab, as the drug is known, in all indications. […]

Read More »

Officials pinpoint NYC hotel in Legionnaires’ outbreak

New York City’s historic Opera House Hotel, identified as the source of a deadly spate of Legionnaires’ disease, said it will go beyond newly imposed regulations in testing its cooling system even as officials declared an end to the outbreak. City officials on Thursday announced an end to the outbreak, which killed 12 people and […]

Read More »

New tool will compare costs and benefits of cancer treatments

As options for cancer patients become increasingly complicated, and expensive, the most influential source for U.S. oncology treatment guidelines will for the first time offer a tool to assess the costs versus benefits of available therapies. The National Comprehensive Cancer Network (NCCN) says its new tool will provide a clearer picture of the relative value […]

Read More »

Depression may increase heart risk in rheumatoid arthritis

Mental health problems like anxiety and depression may partly explain why people with rheumatoid arthritis have an increased risk of cardiovascular disease, according to a new study. Researchers linked anger, anxiety, depressive symptoms, job stress and low social support to increasing risk of hardening of the arteries, or atherosclerosis, for people with rheumatoid arthritis (RA). […]

Read More »

Blackrock NeuroMed, Children’s Hospital of Wisconsin Partner on Groundbreaking Epilepsy Treatment

MILWAUKEE and SALT LAKE CITY, Aug. 21, 2015 /PRNewswire/ — Today, Blackrock NeuroMed LLC and the Children’s Hospital of Wisconsin announced a clinical affiliation that will advance the treatment of childhood epilepsy and provide insight into other neurodegenerative diseases. At the heart of the clinical affiliation is Blackrock NeuroMed’s Cervello System, which allows doctors to examine […]

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2019 Focus: AI, AR/VR, Top 200 Medicines, Lions Health Takeaways, and more!


Ad Right Bottom